Huanqiu Q Li

US Patent:

20110118231, May 19, 2011

Filed:

Nov 19, 2010

Appl. No.:

12/950029

Inventors:

Wilfried Braje - Mannhaim, DE
Stevan W. Djuric - Libertyville IL, US
Noel S. Wilson - Kenosha WI, US
Sean C. Turner - Mannheim, DE
Albert W. Kruger - Pleasant Prairie WI, US
Ana-Lucia Relo - Gonnheim, DE
Shashank Shekhar - Highland Park IL, US
Dennie S. Welch - Lake Bluff IL, US
Hongyu Zhao - Libertyville IL, US
Jorge Gandarilla - North Riverside IL, US
Alan F. Gasiecki - Vernon Hills IL, US
Huanqiu Li - Wilmette IL, US
Christina M. Thompson - Evanston IL, US
Min Zhang - Libertyville IL, US

Assignee:

ABBOTT LABORATORIES - Abbott Park IL
ABBOTT GMBH & CO. KG - Ludwigshafen

International Classification:

A61K 31/554
C07D 487/04
C07D 491/044
C07D 513/04
A61K 31/55
A61K 31/407
A61P 25/28
A61P 25/00
A61P 25/18
A61P 25/24
A61P 25/22
A61P 25/16
A61P 25/08
A61P 25/06
A61P 25/30
A61P 3/04
A61P 3/10
A61P 9/12
A61P 29/00
A61P 15/10
A61P 15/00
A61P 17/06

US Classification:

5142111, 540521, 540577, 548430, 540548, 51421206, 514215, 514411

Abstract:

The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I)wherein R, R, R, R, R, A, Y, Y, and Yare as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

US Patent:

20100298292, Nov 25, 2010

Filed:

May 21, 2010

Appl. No.:

12/784624

Inventors:

Wilfried Braje - Mannheim, DE
Stevan W. Djuric - Libertyville IL, US
Noel S. Wilson - Kenosha WI, US
Sean C. Turner - Mannheim, DE
Albert W. Kruger - Pleasant Prairie WI, US
Ana-Lucia Relo - Gonnheim, DE
Shashank Shekhar - Highland Park IL, US
Dennie S. Welch - Lake Bluff IL, US
Hongyu Zhao - Libertyville IL, US
Jorge Gandarilla - North Riverside IL, US
Alan F. Gasiecki - Vernon Hills IL, US
Huanqiu Li - Wilmette IL, US
Christina M. Thompson - Evanston IL, US
Min Zhang - Libertyville IL, US

Assignee:

Abbott Laboratories - Abbott Park IL
Abbott GmbH & Co. KG - Ludwigshafen

International Classification:

A61K 31/554
C07D 487/04
A61K 31/55
C07D 491/044
A61K 31/407
C07D 513/04
A61P 25/00
A61P 3/04
A61P 3/10
A61P 1/04
A61P 17/06

US Classification:

5142111, 540521, 51421206, 548430, 514411, 540548

Abstract:

The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I)wherein R, R, R, R, R, A, Y, Y, and Yare as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

US Patent:

20180346484, Dec 6, 2018

Filed:

Jan 29, 2018

Appl. No.:

15/882008

Inventors:

- Wiesbaden, DE
- North Chicago IL, US
Stevan W. Djuric - Libertyville IL, US
Noel S. Wilson - Kenosha WI, US
Sean C. Turner - Mannheim, DE
Albert W. Kruger - Pleasant Prairie WI, US
Ana-Lucia Relo - Gonnheim, DE
Shashank Shekhar - Highland Park IL, US
Dennie S. Welch - Lake Bluff IL, US
Hongyu Zhao - Libertyville IL, US
Jorge Gandarilla - North Riverside IL, US
Alan F. Gasiecki - Vernon Hills IL, US
Huanqiu Li - Wilmette IL, US
Christina M. Thompson - Evanston IL, US
Min Zhang - Libertyville IL, US

International Classification:

C07D 513/04
C07D 495/16
C07D 487/04
C07D 495/04
C07D 491/04
C07D 491/044

Abstract:

The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I)wherein R, R, R, R, R, A, Y, Y, and Yare as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

US Patent:

20160096851, Apr 7, 2016

Filed:

Oct 19, 2015

Appl. No.:

14/887171

Inventors:

- Wiesbaden, DE
- North Chicago IL, US
Stevan W. Djuric - Libertyville IL, US
Noel S. Wilson - Kenosha WI, US
Sean C. Turner - Mannheim, DE
Albert W. Kruger - Pleasant Prairie WI, US
Ana-Lucia Relo - Gonnheim, DE
Shashank Shekhar - Highland Park IL, US
Dennie S. Welch - Lake Bluff IL, US
Hongyu Zhao - Libertyville IL, US
Jorge Gandarilla - North Riverside IL, US
Alan F. Gasiecki - Vernon Hills IL, US
Huanqiu Li - Wilmette IL, US
Christina M. Thompson - Evanston IL, US
Min Zhang - Libertyville IL, US

International Classification:

C07D 513/04
C07D 491/044
C07D 495/16
C07D 487/04

Abstract:

The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I)wherein R, R, R, R, R, A, Y, Y, and Yare as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.